Mnp Meditech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 10.04%
(FY 2023)
- Profit 2714.18%
(FY 2023)
- Ebitda 133.35%
(FY 2023)
- Net Worth 152.92%
(FY 2023)
- Total Assets 51.16%
(FY 2023)
About Mnp Meditech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohan Lal and Naveen Pathak serve as directors at the Company.
- CIN/LLPIN
U33100HR2020PTC089182
- Company No.
089182
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Sep 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Faridabad, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Mnp Meditech Private Limited offer?
Mnp Meditech Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Rapid Test Kit, Surgical & Medical Consumables, Medicine Droppers, Sexual Wellness Products, Female Hygiene Products & Test Kits.
Who are the key members and board of directors at Mnp Meditech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Lal  | Director | 13-May-2024 | Current |
| Naveen Pathak | Director | 13-May-2024 | Current |
Financial Performance of Mnp Meditech.
Mnp Meditech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 10.04% increase. The company also saw a substantial improvement in profitability, with a 2714.18% increase in profit. The company's net worth Soared by an impressive increase of 152.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mnp Meditech?
Unlock access to Mnp Meditech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mnp Meditech?
Mnp Meditech has a workforce of 6 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mnp Meditech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mnp Meditech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
